Exendin-4, a glucagon-like peptide-1 receptor agonist, alleviates muscular dysfunction and wasting in a streptozotocin-induced diabetic mouse model compared to metformin
Tissue and Cell · 2024
DOI: 10.1016/j.tice.2024.102479 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Tissue and Cell, 2024. Verfasst von Ding-Cheng Chan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics and Gerontology, College of Medicine and Hospital, National Taiwan University, Taipei, Taiwan, Republic of China. Hauptthemen laut MEDLINE: Exenatide, Diabetes Mellitus, Experimental, Metformin, Glucagon-Like Peptide-1 Receptor. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: National Science and Technology Council.
Abstract (Originalsprache)
Diabetic muscular atrophy is becoming a fast-growing problem worldwide, including sarcopenia, which is associated with substantial mortality and morbidity risk. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have been marketed and suggested to exert protective effects on not only glycemic control but also diabetic complications in diabetic patients. In this study, we investigated the therapeutic use of GLP-1RAs exendin-4, compared to antidiabetic drug metformin, for the intervention of muscular dysfunction during diabetic conditions using a streptozotocin (STZ)-induced diabetic mouse model. The results showed that both exendin-4 and metformin could effectively alleviate hyperglycemia in diabetic mice, and also counteract diabetes-induced muscle weight loss, weaker grip, and changes in muscle fiber cross-sectional area distribution. Unexpectedly, exendin-4, but not metformin, enhanced the increased kidney weight and histological change in diabetic mice. Taken together, these findings suggest that both exendin-4 and metformin could effectively improve the diabetic hyperglycemia and muscular dysfunction; but exendin-4 may aggravate the nephropathy in STZ-induced diabetic mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics and Gerontology, College of Medicine and Hospital, National Taiwan University, Taipei, Taiwan, Republic of China.
- Institute of Toxicology, National Taiwan University, Taipei, Taiwan, Republic of China.
- Department of Orthopedics, College of Medicine and Hospital, National Taiwan University, Taipei, Taiwan, Republic of China.
- Department of Food Science, National Taiwan Ocean University, Keelung, Taiwan, Republic of China. Electronic address: a0071@mail.ntou.edu.tw.
- Institute of Toxicology, National Taiwan University, Taipei, Taiwan, Republic of China; Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan, Republic of China; D…
Förderung
- National Science and Technology Council
Zitieren
APA
Chan, D. C., Lin, Y. C., Tzeng, H. P., Yang, R. S., Chiang, M. T., & Liu, S. H. (2024). Exendin-4, a glucagon-like peptide-1 receptor agonist, alleviates muscular dysfunction and wasting in a streptozotocin-induced diabetic mouse model compared to metformin. Tissue and Cell. https://doi.org/10.1016/j.tice.2024.102479
Vancouver
Chan DC, Lin YC, Tzeng HP, Yang RS, Chiang MT, Liu SH. Exendin-4, a glucagon-like peptide-1 receptor agonist, alleviates muscular dysfunction and wasting in a streptozotocin-induced diabetic mouse model compared to metformin. Tissue and Cell. 2024. doi:10.1016/j.tice.2024.102479
BibTeX
@article{Chan2024,
author = {Chan, Ding-Cheng and Lin, Yuan-Cheng and Tzeng, Huei-Ping and Yang, Rong-Sen and Chiang, Meng-Tsan and Liu, Shing-Hwa},
title = {Exendin-4, a glucagon-like peptide-1 receptor agonist, alleviates muscular dysfunction and wasting in a streptozotocin-induced diabetic mouse model compared to metformin},
journal = {Tissue and Cell},
year = {2024},
doi = {10.1016/j.tice.2024.102479}
}
EUVIMED